Athira Pharma
ATHA
ATHA
93 hedge funds and large institutions have $234M invested in Athira Pharma in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $251M → $234M (-$17.5M)
43% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $3.62M
Holders
93
Holding in Top 10
–
Calls
$2.08M
Puts
$3.62M
Top Buyers
| 1 | +$4.55M | |
| 2 | +$4.17M | |
| 3 | +$4.15M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.57M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.84M |
Top Sellers
| 1 | -$6.95M | |
| 2 | -$4.56M | |
| 3 | -$3.06M | |
| 4 |
VA
VR Adviser
New York
|
-$2.71M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.04M |